Picture of Shenzhen Hepalink Pharmaceutical Co logo

9989 Shenzhen Hepalink Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Shenzhen Hepalink Pharmaceutical Announces FY Loss Attributable Of RMB783.3 Mln

March 28 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd  002399.SZ :
    * FY LOSS ATTRIBUTABLE RMB783.3 MILLION VERSUS PROFIT
RMB727.4
MILLION
    * FY REVENUE RMB5,431.0 MILLION VERSUS RMB7,151.0 MILLION

Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shenzhen Hepalink Pharmaceutical Co

See all news